Deltex is known as a Notch signal mediator, but its physiological action mechanism is poorly understood. 
Deltex was first identified in Drosophila spp. for its interaction with Notch. Deltex contains an N-terminal basic region, for binding to the ankyrin repeats of the Notch intracellular region, a proline-rich motif, and a RING finger domain at its C terminus. Deltex is a positive modulator of Notch in Drosophila (30) . The mammalian Deltex1 is the homologue most closely related to the Drosophila Deltex (31) . Deltex1 has been shown to be a transcription target gene of Notch (7) . Interestingly, overexpression of Deltex1 directs lymphoid development towards B-cell production concurrent with suppression of Tcell development (17, 53) . Consistent with these observations, Deltex1 is overexpressed in marginal zone B cells (38) and in germinal center B cells (12) . The precise action mechanism of Deltex remains elusive (28) . Deltex binds to Grb2 and has been shown to inhibit E2A (31) . Deltex inhibits Jun-mediated transcription, suggested to be at the stage of Ras-dependent Jun N-terminal protein kinase (JNK) activation (35). Deltex1, acting as a Notch downstream transcription regulator, has also been shown to interact with the transcription coactivator p300 and to inhibit transcription activation mediated by the neural specific transcription factor MASH1 (50) . However, these reported effects cannot account for the biological events mediated by Deltex (17) .
The ubiquitin-proteasome system controls intracellular protein degradation (13, 37) . Ubiquitination starts from ATPdependent and ubiquitin-activating enzyme (E1)-mediated ubiquitin conjugation to E1, followed by ubiquitin-conjugation enzyme (E2)-catalyzed transesterification of the E1-attached ubiquitin to E2. Ubiquitin-protein isopeptide ligase (E3), binding specifically to both E2 and the target protein, then promotes the transfer of ubiquitin to the target protein. From their structures, E3 enzymes have been classified into two distinct types: those possessing a HECT domain and those with a RING finger (18, 20) . RING fingers are zinc-binding motifs with eight conserved cysteine and histidine residues. As RING finger proteins, Deltex family members were recently found to possess ubiquitin-protein isopeptide ligase (E3) activity (41) . Through its own E3 activity, Deltex promotes self-ubiquitination (41) ; however, the in vivo substrate of DTX E3 ligase remains unknown.
Mitogen-activated protein kinase (MAPK) cascades mediate signal transduction from external stimulus to the nuclei (25, 36) . MAP kinase kinase kinase 1 (MEKK1) is a 195-kDa protein with a C-terminal protein kinase domain and a large noncatalytic N terminus (26, 48) . MEKK1 is processed by caspase-3-like protease to generate the 91-kDa C terminus kinase domain [MEKK1(C)] (43) . Although MEKK1 is a primary activator for JNK through phosphorylation of stress-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (SEK, MKK4) (33, 43, 48, 51) , MEKK1 can also regulate the ERK pathway (22, 49) . Target gene disruption of MEKK1 has been shown to eliminate stress-induced JNK activation and reduce hyperosmolarity-and serum-stimulated ERK activation (47, 52) . MEKK1 binds to a number of signaling proteins such as JNK, ERK2, MKK4, Raf-1, RhoA, TRAF2, and germinal center kinase (2, 3, 10, 22, 47, 49) . Among these interactions, the simultaneous binding of MEKK1 to TRAF2 and germinal center kinase results in the activation of MEKK1 (2, 3) . However, the in vivo significance of most MEKK1-dependent interactions remains unclear (10) .
In the present study, we observed that Deltex is a physiological regulator of T-cell activation. Deltex inhibited T-cell activation not at the stage of T-cell receptor engagement but at the levels of MAPK activation. One of the defects identified in Deltex-overexpressing T cells was the diminished levels of MEKK1(C). We further demonstrated that Deltex is a ubiquitin E3 ligase for MEKK1(C). Our results reveal a novel function of Deltex through selective degradation of MEKK1.
Gauge software (version 3.2; Fuji). Quant mode was used to select the reading area and to subtract background. The reading of the sample from the control T cells (mock transfected or pSuper vector transfected) was then set as 1 to get the preliminary n-fold of change for the siRNA-transfected T-cell samples. The final n-fold of change was obtained after normalization with ␤-tubulin contents.
GST pull-down assay. His 6 -MEKK1(C) and His 6 -MEKK1(FL) were produced by subcloning MEKK1(C) (874 to 1493 amino acids) and MEKK1(FL) (1 to 1493 amino acids), respectively, into pRSET-a (Invitrogen) for N-terminal His 6 flanking. Recombinant His 6 -MEKK1(C) and His 6 -MEKK1(FL) were then purified on Ni-nitrilotriacetic acid (NTA) agarose (QIAGEN). Cell lysates for the GST pull-down assay were prepared in GSH binding buffer (50 mM potassium phosphate buffer, pH 7.5, 150 mM KCl, 1 mM MgCl 2 , 10% glycerol, 1% Triton X-100, 1% aprotinin, 1 mM phenylmethylsulfonyl fluoride). Five micrograms of GSTfusion protein (GST-Deltex) was loaded onto GSH agarose (20 l, 50% slurry) and incubated with 100 to 200 g of cell lysates overnight at 4°C or with 5 g of His 6 -MEKK1(C) or His 6 -MEKK1(FL) for 2 h at 4°C. GST agarose beads were then washed three times with binding buffer and analyzed on SDS-PAGE.
In vitro ubiquitination assay. The in vitro ubiquitination reaction mixture contained bovine ubiquitin (1 g), rabbit E1 (0.2 g), UbcH5c (0.2 g), GSTDeltex (0.2 g), and His 6 -MEKK1(C) (0.5 g) in 20 l of reaction buffer (25 mM Tris, pH 7.5, 50 mM NaCl, 10 mM MgCl 2 , 2 mM ATP, 0.5 mM dithiothreitol). The reaction proceeded at 30°C for 30 min. Eighty microliters of reaction buffer and 20 l of 50% slurry Ni-NTA agarose were then added and mixed at 4°C for 2 h to pull down His 6 -MEKK1(C). Ni-NTA agarose was then washed three times with ice-cold reaction buffer, resuspended in SDS sample buffer, and resolved on SDS-PAGE. The amount of ubiquitin associated was determined by blotting with ubiquitin antibody.
RESULTS

Physiological role of Deltex in T-cell activation.
To delineate the potential function of Deltex, we first examined the expression of Deltex T lymphocytes. Deltex1 mRNA and protein were constitutively expressed in resting DO11.10 T hybridomas, EL4 T lymphomas, and normal splenic T cells (Fig. 1A to E). A notable trait of Deltex1 expression is its high sensitivity to T-cell receptor engagement. Anti-CD3 and anti-CD28 treatment resulted in immediate reduction of Deltex levels in DO11.10 T cells, as shown by disappearance of Deltex mRNA 30 min after TCR activation, corresponding to a largely diminished Deltex1 protein level 30 min after TCR ligation ( Fig. 1A  and C) . A similar attenuation of Deltex1 expression was found in splenic T cells upon anti-CD3 stimulation (Fig. 1B and D) . TCR-mediated decrease of Deltex suggests a negative role of Deltex in T-cell activation. To further confirm the physiological role of Deltex as a regulator for T-cell activation, we used siRNA to down-regulate the endogenous Deltex1 expression. Transfection of Deltex1-specific siRNA effectively reduced the levels of Deltex1 mRNA and protein in both DO11.10 and EL4 T cells ( Fig. 1E ; data not shown for mRNA). Down-regulation of Deltex expression resulted in enhanced TCR-stimulated IL-2 production in both DO11.10 and EL4 T cells ( Fig. 1F and G). The specificity of Deltex siRNA was illustrated by the fact that expression of Deltex1 reversed the stimulatory effect of Deltex siRNA in EL4 cells (Fig. 1H) . Therefore, Deltex is an antagonist of T-cell activation in vivo.
Deltex inhibits TCR-mediated IL-2 production in T cells. To examine how Deltex modulates the activation of T cells, Myctagged murine Deltex1 was introduced into DO11.10, EL4, and preactivated splenic T cells. The retroviral infected DO11.10 and splenic T cells, marked by YFP expression, were sorted on a flow cytometer. The expression of deltex1 was confirmed by Myc-specific antibody ( Fig. 2A) . T cells were stimulated either with immobilized CD3/CD28 antibodies or with antigenic peptide presented by A20 B cells. The effect of Deltex expression was assessed by difference in activation between YFP-and Deltex1-DO11.10 T cells. The level of IL-2 produced after CD3/CD28 engagement (Fig. 2B ) or antigen stimulation (Fig. 2C ) was significantly reduced in DO11.10 T cells transduced with Deltex1 compared with the control YFP cells. Similarly, Deltex expression suppressed T-cell activation in EL4 cells (Fig. 2D) . Inhibition of T-cell activation by Deltex was not restricted to transformed T cells. Expression of Deltex1 in purified splenic T cells profoundly inhibited CD3-triggered IL-2 secretion (Fig. 2E ).
Deltex suppresses TCR-mediated activation of JNK, ERK, and p38 MAPK but not of LAT and PKC. Since the expression of IL-2 in naive T cells is determined primarily by transcription activation of the IL-2 gene promoter (19), we next determined whether activation of the major transcription elements, NF-B, NFAT, and AP-1 on the IL-2 gene promoter were affected by Deltex1 cotransfection. Deltex did not affect the activation of NF-B (Fig. 3A) , while it partially inhibited the induction of NFATc (Fig. 3B ) and c-Fos (Fig. 3C ) and effectively prevented c-Jun phosphorylation (Fig. 3D) . Consis- VOL. 25, 2005 Deltex IS AN E3 UBIQUITIN LIGASE FOR MEKK1 1369 tent with results on the nuclear appearance of the specific transcription factor, overexpression of Deltex in T cells repressed the activation of IL-2-CAT and AP-1-CAT (data not shown). JNK, ERK, and p38 MAPK contribute to c-Fos induction, c-Jun activation, and NFATc expression (23, 25, 46) . We then determined the effect of Deltex on activation of JNK, ERK, and p38 MAPK. Consistent with a reduction in c-Jun Ser63 phosphorylation, CD3/CD28-triggered JNK activation, measured by phosphorylation of GST c-Jun (1-79), was largely attenuated in EL4 and DO11.10 T cells expressing Deltex1 ( Fig. 4A ; data not shown for DO11.10). A moderate decrease in ERK activation, assessed by phosphorylation of ERK, was also found in DO11.10 and EL4 T cells expressing Deltex1 compared with the YFP control ( Fig. 4B ; data not shown for EL4). An effective inhibition of p38 MAPK was observed in Deltex-expressing T cells (Fig. 4C ). We thus studied whether defective MAPK activation could be attributed to an inhibition on proximal TCR activation by Deltex. TCR engagement is immediately followed by recruitment and tyrosine phosphorylation of the adaptor protein LAT; LAT is pivotal for activation of AP-1 and ERK (40) . Figure 4D illustrates that anti-CD3 stimulation of T cells led to extensive LAT phosphorylation, identical in Deltex1-DO11.10 and YFP-DO11.10 cells, suggesting that Deltex1 does not affect early T-cell activation at the stage of LAT phosphorylation. We also determined the activation of PKC, another key signaling molecule in early T-cell activation (16) . PKC has been shown to stimulate Ras-dependent transcription activation of AP-1 in T cells and to cooperate with calcineurin for JNK activation and IL-2 gene expression (1, 42) . The level of PKC phosphorylation after TCR ligation was also similar for the Deltex-expressing T cells and the YFP control (Fig. 4D) . Therefore, the stages of TCR activation that are regulated by Deltex1 should be downstream of the LAT and PKC activation. (Fig. 5B) . A significant reduction in MEKK1(C) was found in Deltex1-DO11.10 T cells compared to the control YFP T cells. In contrast, the protein levels of MEKK1(FL) were not altered by Deltex1 expression relative to the control (Fig. 5B) . MEKK1 mRNA expression also was not affected in Deltex1-DO11.10 T cells (Fig. 5C) , suggesting that the reduced protein levels of MEKK1(C) were not due to transcription inhibition by Deltex. A similar extent of MEKK1(C) down-regulation by Deltex1 was observed in EL4 T cells (data not shown). We also examined the effect of Deltex on normal T cells. In purified splenic T cells, almost all MEKK1 was processed into the catalytic active form [MEKK1(C)], with no MEKK1(FL) detected (Fig. 5D ). Ectopic expression of Deltex1 led to the complete elimination of MEKK1(C) in splenic T cells. We further examined whether reduction of Deltex1 would enhance MEKK1(C) levels in resting T cells. Consistent with the prominent decrease of endogenous Deltex by the transfected Deltex1 siRNA (Fig. 1E) , MEKK1(C) was increased in DO11.10 and EL4 cells expressing Deltex1 siRNA (Fig. 5E ). Densitometry reading indicated a twofold increase of MEKK1(C) in T cells when endogenous Deltex was knocked down. Because the presence of MEKK1(C) as the dominant form of MEKK1 in T cells has not been previously documented, we also determined whether our experimental procedures may lead to procession of MEKK1(FL) to MEKK1(C) and overrepresentation of MEKK(C) in our T-cell preparations. Figure 5F illustrates that MEKK1(FL) was the major form in non-T cells including A20, splenic B cells, NIH 3T3, and RAW264.7, for which cell lysates were isolated simultaneously with the T-cell preparations in the same blot. The distinct MEKK1 expression pattern between T cells and non-T cells suggests that the predominant presence of MEKK1(C) in T cells is not an artifact of cell extract preparation. Since Deltex1 is down-regulated by TCR and anti-CD28 (2.5 g/ml) and total cellular extracts were prepared at the indicated time points. JNK1 was then immunoprecipitated from cellular extracts (100 g), and the kinase activity of the immune complexes was determined using GST-c-Jun (1-79) as substrate. The amount of JNK1 in 20% of the immune complexes was determined by immunoblotting. (B and C) Deltex interfered with p42/p44 ERK activation and p38 MAPK stimulation. ERK and p38 activation in DO11.10 T cells before and after CD3/CD28 (5 versus 2.5 g/ml) stimulation was determined using anti-phosphorylated T202/Y204 ERK and anti-phospho-T180/Y182 p38 MAPK, respectively. The levels of ERK2 and p38␣ MAPK were used as an internal control. (D) Deltex did not affect TCR-mediated LAT and PKC activation. LAT and PKC activation in YFP-or Deltex1-DO11.10 T cells were determined using anti-phospho-LAT (Y191) and anti-phospho-PKC (T538). The protein level of ␤-tubulin was used as an internal control. (Fig. 1A to D) , we also determined changes in MEKK1 levels after T cells were stimulated. Parallel to the reduction of Deltex1 following anti-CD3 treatment (Fig. 1) , MEKK1 protein was proportionally increased in splenic T cells (Fig. 6A) . TCR-initiated increase of MEKK1 expression was restricted to the protein level; MEKK1 mRNA remained unchanged after TCR engagement (Fig. 6B) . Therefore, Deltex specifically down-regulates MEKK1(C) protein in T cells. on September 8, 2017 by guest http://mcb.asm.org/ pression, how T-cell activation would be affected could not be deduced because MEKK1 has not been demonstrated to be essential for T-cell activation. We thus studied whether MEKK1 down-regulation by siRNA would lead to an inhibition of IL-2 expression similar to that seen on Deltex-expressing T cells. MEKK1-specific siRNA was introduced into DO11.10 and EL4 cells by electroporation. There was a more than 80% reduction in the protein level of MEKK1 by siRNA transfection (Fig. 6C ). This was accompanied by a significant decrease in CD3/CD28-stimulated IL-2 expression in both EL4 and DO11.10 cells (Fig. 6D and E) . In addition, CD3/CD28-stimulated JNK activity was attenuated when MEKK1 was knocked down by siRNA (Fig. 6F) . Therefore, MEKK1 is indispensable for JNK stimulation and T-cell activation. The Deltex-mediated T-cell inactivation could be attributed, at least in part, to the down-regulation of MEKK1.
Ubiquitin-mediated MEKK1(C) degradation in Deltex-expressing T cells.
To examine whether the Deltex-directed 
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on September 8, 2017 by guest http://mcb.asm.org/ MEKK1(C) reduction was due to proteasome-dependent degradation, T cells were treated with the proteasome inhibitor MG132. MG132 treatment had no effect on the level of MEKK1(FL) and MEKK1(C) in YFP control T cells (Fig. 7A) . In contrast, MG132 restored MEKK1(C) expression in Deltex1-expressing T cells, indicating that Deltex1 triggered MEKK1(C) degradation in a proteasome-dependent manner (Fig. 7A) . We next determined whether Deltex1 promoted the ubiquitination of MEKK1(C). MEKK1 was precipitated from T cell lysate and immunoblotted with antiubiquitin. MEKK1 was not ubiquitinated in control YFP T cells (Fig. 7B) . However, ubiquitin modification of MEKK1(C), characterized by the presence of multiple MEKK1 protein bands, was evident in T cells expressing Deltex1. The level of MEKK1(C) ubiquitination was prominent when protein degradation was blocked by addition of MG132 to Deltex1-DO11.10 T cells (Fig. 7B) . Similar results were found in splenic T cells, where Deltex1 expression resulted in extensive MEKK1 ubiquitination (Fig.  7C ). Since MEKK1(C) is the only form of MEKK1 in splenic T cells (Fig. 5D) , the high-molecular-weight ubiquitin conjugates (Fig. 7C ) apparently came from MEKK1(C). These results suggest that Deltex1 targets MEKK1(C) for ubiquitin conjugation and concomitant proteasome-mediated degradation in T cells. Deltex interacted with MEKK1(C) but poorly with the fulllength MEKK1. Inasmuch as Deltex1 promoted MEKK1 ubiquitination, we elucidated whether there is a direct association between Deltex1 and MEKK1. For overexpression purposes, 293T cells were used. MEKK1(FL) or MEKK1(C) was transfected into 293T cells in the presence or absence of Myctagged Deltex1. Overexpression of MEKK1(FL) resulted in the appearance of both full-length and the catalytic active MEKK1 (Fig. 8A) . Immunoprecipitation with anti-Myc antibodies brought down Myc-tagged Deltex1 and MEKK1(C) but not the full-length MEKK1 (Fig. 8A) , suggesting that Deltex1 interacts with MEKK1(C) but poorly with MEKK1(FL). We further used a GST pull-down assay to examine the protein interaction between Deltex and MEKK1(C). Incubation of bacterial expressed GST-Deltex1 with lysates from 293T cells overexpressing MEKK1(FL) or MEKK1(C) brought down MEKK1(C) (Fig. 8B) . Endogenous MEKK1(C) from DO11.10 T cells was also pulled down by GST-Deltex1 (Fig. 8B) . The direct binding of Deltex to MEKK1(C) was confirmed by the association of GST-Deltex with His-MEKK1(C) when only these two recombinant proteins were presented (Fig. 8C) . Removal of the RING finger domain from Deltex did not affect its interaction with MEKK1(C). In contrast, no interaction between GST-Deltex1 and His-MEKK1(FL) was detected in the same assay (Fig. 8C) . Taken together, Deltex1 interacted with the C-terminal fragment of MEKK1.
Deltex induces MEKK1(C) ubiquitination in vivo.
The Cterminal region of Deltex contains a RING finger, a domain shared by several ubiquitin E3 ligases. Human Deltex family members have been shown to function as an E3 ligase in vitro (41) . The observed association between Deltex1 and MEKK1 (C) (Fig. 8) and the down-regulation of MEKK1(C) by Deltex1 (Fig. 7) suggested that Deltex may act as an E3 ligase which binds MEKK1(C) and mediates the transfer of ubiquitin to MEKK1(C), leading to degradation of MEKK1(C) by the proteasome. To assess whether Deltex could target MEKK1(C) for ubiquitination, we transfected 293T cells with FLAGtagged ubiquitin (FLAG-Ub) and MEKK1(C) in the presence or absence of Deltex-Myc. Ubiquitinated proteins were immunoprecipitated with FLAG-M2 affinity gel and the level of ubiquitinated MEKK1 was analyzed by using MEKK1 antibodies. Figure 9A demonstrates that MEKK1(C) was ubiquitinated only with the coexpression of Deltex. To determine if the (Fig. 8C ) but abolished the capacity of Deltex1 to trigger MEKK1(C) ubiquitination (Fig. 9A) . These results demonstrated that DTX acts as an E3 ligase for the ubiquitination of the C-terminal of MEKK1 in vivo.
Deltex promotes MEKK1(C) ubiquitination in vitro.
We further conducted the in vitro ubiquitination analysis to confirm the role of DTX as a ubiquitin E3 ligase for MEKK1(C). In mixtures containing only ubiquitin, E1, E2 (UbcH5c), and recombinant MEKK1(C), no ubiquitination of MEKK1(C) was detected (Fig. 9B) . The addition of recombinant GSTDeltex to the same reaction mixture stimulated the ubiquitination of MEKK1(C). In contrast, no ubiquitination of MEKK1(C) was detected if the Deltex1 mutant with the RING finger deleted (GST-DTX⌬RF) was added to the same reaction, suggesting that the RING finger domain is required for Deltex to induce MEKK1(C) ubiquitination.
DISCUSSION
Despite the fact that many physiological functions are assigned to Deltex, the action mechanisms of Deltex remain largely elusive. In the present study, we demonstrated a new function of Deltex in T cells and a novel mechanism of Deltex in regulating T-cell signaling. Deltex expression was constitutive in resting T cells (Fig. 1A to E) and was subjected to a profound down-regulation by TCR ligation. The levels of Deltex1 mRNA and protein were immediately decreased following TCR stimulation and were nearly undetectable in T cells 45 min after anti-CD3 stimulation. TCR-mediated Deltex1 reduction could be due to an inhibitory effect on Deltex1 mRNA expression (Fig. 1A and B) . The exact activation signals that Since T cells were activated by plate-bound antibody, in the absence of contact with antigen-presenting cells (Fig. 1) , the regulation of Deltex expression by TCR stimulation was apparently independent of Notch signals.
We also used Deltex-specific siRNA to demonstrate the physiological role of Deltex in regulating T-cell activation (Fig.   1E to G). Even if Deltex1 levels were attenuated by TCR stimulation (Fig. 1A to D) , a reduced Deltex1 expression prior to T-cell activation further enhanced TCR-stimulated IL-2 production, suggesting a pivotal role of Deltex in T-cell activation events. Several signaling pathways affected by Deltex, including activation of AP-1 and NFATc and stimulation of JNK, p38 MAPK, and ERK, were identified by Deltex1 overexpression ( Fig. 3 and 4) . Most of these activation defects are known to be involved in T-cell activation. For example, previous studies have established a critical role of p38 MAPK in T-cell activation (15, 29, 39, 46) , that interference of p38 MAPK activation severely impairs T-cell activation. For NFAT and AP-1, their coordinated association on the IL-2 gene promoter dictates the expression of the IL-2 gene (19) . Interestingly, with the profound inhibition of quite a few downstream signals, the proximal TCR activation events were mostly unaffected by Deltex1. The activation of LAT and PKC was normal in the presence of Deltex overexpression (Fig. 4D) . Instead, one of the defects was mapped to selective degradation of MEKK1 (Fig. 5B) . This was best illustrated by the exact inverse correlation between the expression of Deltex1 and the levels of MEKK1 in T cells. In the absence of any Deltex1 overexpression, TCR stimulation down-regulated Deltex1, with a simultaneous up-regulation of MEKK1 (Fig. 1A to D and Fig. 6A ). In addition, reduced Deltex1 expression by siRNA in T cells (Fig. 1E) led to a significant increase of MEKK1(C) protein (Fig. 5E) .
Interference of JNK activation by Deltex has been previously suggested, based on the suppression of Ras-dependent c-Jun activation by Deltex (35) . The present study provides the first direct proof that JNK activation is profoundly attenuated by Deltex (Fig. 4A) . We also found that ERK activation was partially inhibited by Deltex1 (Fig. 4B) . It has been shown that MEKK1 gene knockout results in severe reduction in JNK activity and mild inhibition of ERK activity (52), a phenotype similar to our Deltex1-expressing T cells. Despite the fact that the link between MEKK1 and p38 MAPK is less direct (52), p38 MAPK has been shown to be activated by MEKK1 in many different cells (6, 8, 11, 44, 46) . Therefore, defects in the activation of JNK, p38 MAPK, and ERK in Deltex1-expressing T cells could be attributed, at least in part, to the downregulation of MEKK1(C). It has to be noted that we do not exclude the possibility that Deltex expression leads to defects in additional signal molecules and contributes to the aberrant MAPK activation observed here.
Our results further demonstrated, likely for the first time, that MEKK1 is essential for TCR signal transduction. There are more than 12 different MAP kinase kinases in mammalian cells (25, 36) , suggesting a possible signaling redundancy among several MAP kinase kinases, which makes defining the specific involvement of a MAP kinase kinase downstream of the T-cell receptor difficult. Activation of MEKK1 by TCR ligation has been previously demonstrated (1, 21) . Whether MEKK1 is essential for T-cell activation, however, remains unclear. Our observations that down-regulation of MEKK1 by Deltex resulted in inactivation of JNK and p38 MAPK and a decrease in IL-2 generation (Fig. 2, 4 , and 5), together with the finding that T-cell activation was suppressed when MEKK1 was specifically reduced by siRNA (Fig. 6) , clearly support an indispensable role of MEKK1 in T-cell activation. A critical observation from the present study is the identification of MEKK1 as a substrate of Deltex E3 ligase. The C terminus of Deltex is a RING finger, a domain present in many E3 ligases and functioning to bind E2 (18, 20) . Deltex1 has since been shown to exhibit E3 ligase activity based on its ability to promote self-ubiquitination (41) , despite the fact that the in vivo targets of Deltex1 E3 activity remain unknown. Our results illustrate the in vivo E3 ligase activity of Deltex1 and identify MEKK1(C) as the first known physiological target of Deltex E3 ligase. Deltex interacted directly with MEKK1(C), as shown by coimmunoprecipitation and GST pull-down analysis (Fig. 8) . Deltex1 bound substrate MEKK1(C) through a region distinct from its RING finger (Fig. 8C) , consistent with the function of the RING finger for E2 association. Deltex1 promoted MEKK1(C) ubiquitination when coexpressed with MEKK1(C) in cells (Fig. 9A) or coincubated with recombinant MEKK1(C) in the presence of E1 and E2 (Fig. 9B) . Deletion of the RING finger, the E2-binding domain, abolished the ability of Deltex1 to stimulate MEKK1(C) ubiquitination (Fig.  9B ) despite the fact that Deltex1 still interacted with MEKK(C) (Fig. 8C ). Deltex1 fulfills all the criteria for an E3 ligase specific for MEKK1(C).
Another important finding here is that Deltex is a ubiquitin ligase for MEKK1(C) but much less so for MEKK1(FL). In contrast to the effective interaction between MEKK1(C) and Deltex1, the binding of MEKK1(FL) to Deltex was minimum (Fig. 8) . The ability of a substrate to bind to a specific E3 is a prerequisite for ubiquitin transfer mediated by the given E3. The differential effect of Deltex1 on the degradation of MEKK1(C) and MEKK1(FL), therefore, could be attributed to the distinct binding affinity for Deltex1 between MEKK1(C) and MEKK1(FL). At present, the cause for the poor interaction between MEKK1(FL) and Deltex is not understood. In addition to the C-terminal kinase domain, the full-length MEKK1 contains a long N-terminal domain (48) with prolinerich domains for binding to SH3, sequences for binding to 14-3-3, and pleckstrin homology domains (25, 36) . A possibility is that interaction of MEKK1(FL) with other signaling molecules in vivo prevents the binding of Deltex to MEKK1(FL). Alternatively, the long N-terminal region of MEKK1(FL) may shield the Deltex-binding area of MEKK1(C) from Deltex interaction. A study is ongoing to delineate these two possibilities.
It is interesting that recent findings show that the plant homeodomain of MEKK1 is an E3 ubiquitin ligase and mediates the degradation of ERK (27, 45) . Together with results from the present study, there are two parallel ubiquitin conjugation pathways centered on MEKK1; MEKK1(C) is degraded through ubiquitination by Deltex E3, while MEKK1(FL) acts as an E3 for other signaling proteins. A potential physiological significance of the resistance of MEKK1(FL) to Deltex1-mediated ubiquitination could be an assurance of the operation of the MEKK1(FL) E3 pathway by preventing unnecessary degradation of MEKK1(FL).
Both full-length MEKK1 and MEKK1(C) activate JNK; the processing of full-length MEKK1 to MEKK1(C) is not essential for activation of JNK (43) . Blockage of caspase-mediated MEKK1 cleavage by specific inhibitors does not interfere with the downstream JNK and ERK activation, and neither does mutation of the caspase-3 recognition sites (DEVE3A 860 and DTVD3A 874 ) on MEKK1 affect JNK activation (43) . Therefore, MEKK1(FL) may convey sufficient JNK activation in the absence of MEKK1(C) generation. MEKK1(C), however, is the dominant form of MEKK1 in T cells (Fig. 5F ). Deltexmediated degradation of MEKK1(C) eliminates most of MEKK1 in T cells (Fig. 5B and D) , leading to defective T-cell activation.
In summary, we identified a novel pathway regulating MEKK1 stability and T-lymphocyte activation by the Notch signal mediator Deltex. As an E3 ligase, Deltex1 binds specifically to its target MEKK1(C) and mediates the transfer of ubiquitin from the RING finger-associated E2 to MEKK1(C). MEKK1(C) is a key to T-cell activation (Fig. 6 ) and its degradation by proteasome results in defective T-cell activation. The ubiquitin E3 ligase activity of Deltex is clearly dissociated from the transcription activity reported for Deltex (50) and may contribute to physiological activities previously thought to be Deltex independent. We are currently working to identify other substrates targeted by Deltex E3 ligase, which will help unveil additional functional roles of Deltex.
